Skip to main content
TipRanks
Go Ultimate75% OFF

Xtl Bio (XTLB) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Xtl Bio has a market cap or net worth of ILA 25.11M. The enterprise value is ILA 5.24T.

Market Cap
ILA 25.11M
Enterprise Value
ILA 5.24T

Share Statistics

Xtl Bio has 1,793,390,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
1,793,390,500
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Xtl Bio’s return on equity (ROE) is 27.44 and return on invested capital (ROIC) is -11253.33%.

Return on Equity (ROE)
27.44
Return on Assets (ROA)
-41.98
Return on Invested Capital (ROIC)
-11253.33%
Return on Capital Employed (ROCE)
6.65
Revenue Per Employee
0
Profits Per Employee
-696.90K
Employee Count
10
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Xtl Bio is -0.54. Xtl Bio’s PEG ratio is 0.01.

PE Ratio
-0.54
PS Ratio
0.00
PB Ratio
-15.35
Price to FCF
-4.17
Price to Operating Cash Flow
-3.80
PEG Ratio
0.01

Income Statement

In the last 12 months, Xtl Bio had revenue of 0 and earned -6.97M in profits. Earnings per share was -0.01.

Revenue
0
Gross Profit
0
Operating Income
-1.69M
Pretax Income
-759.00K
Net Income
-6.97M
EBITDA
-1.27M
Earnings Per Share (EPS)
-0.01

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
-0.00

Dividends & Yields

Xtl Bio pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-23.92%
Earnings Yield
-178.36%

Stock Price Statistics

Beta
0.51
52-Week Price Change
-58.82%
50-Day Moving Average
1.64
200-Day Moving Average
2.02
Relative Strength Index (RSI)
40.28
Average Volume (3m)
970.06K

Financial Position

Xtl Bio as a current ratio of 0.40, with Debt / Equity ratio of -105.91%

Current Ratio
0.40
Quick Ratio
0.40
Debt to Market Cap
0.04
Net Debt to EBITDA
-0.15
Interest Coverage Ratio
-241.14

Taxes

In the past 12 months, Xtl Bio has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Xtl Bio EV to EBITDA ratio is -3.54, with an EV/FCF ratio of -4.37.

EV to Sales
0.00
EV to EBITDA
-3.54
EV to Free Cash Flow
-4.37
EV to Operating Cash Flow
-4.37

Balance Sheet

Xtl Bio has ILA 259.00K in cash and marketable securities with ILA 86.00K in debt, giving a net cash position of ILA 173.00K billion.

Cash & Marketable Securities
ILA 259.00K
Total Debt
ILA 86.00K
Net Cash
ILA 173.00K
Net Cash Per Share
ILA 0.00
Tangible Book Value Per Share
ILA 0.00

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Xtl Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
―